Managing drug therapy in patients receiving enteral and parenteral nutrition

Hospital Pharmacist

Volumn 7, Issue 6, 2000, Pages 155-164

  Thomson, F C ^a,e   Naysmith, M R ^c,d,e   Lindsay, A ^b,e  

^a SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^b VICTORIA INFIRMARY   (United Kingdom)

^c Intensive Care Unit

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTICONVULSIVE AGENT; BENSERAZIDE PLUS LEVODOPA; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CIPROFLOXACIN; DIGOXIN; FUSIDATE SODIUM; HYDRALAZINE; LEVODOPA; LITHIUM; PENICILLIN V; PHENYTOIN; PROPOFOL; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCRALFATE; THEOPHYLLINE; WARFARIN;

CATHETER; CONTROLLED RELEASE FORMULATION; DRUG ABSORPTION; DRUG CAPSULE; DRUG FORMULATION; ENTERIC FEEDING; FOOD DRUG INTERACTION; HUMAN; LIQUID; PARENTERAL NUTRITION; PHARMACIST; REVIEW; TABLET; TOTAL PARENTERAL NUTRITION; TUBE;

EID: 0033833002     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Malnutrition in hospital patients
2. Inside story
3. Diet and drug interactions
4. Assessment of drug-related problems in clinical nutrition patients
5. Nasogastric drug administration
6. Administration of medications through enteral feeding catheters
7. Warfarin resistance associated with intravenous lipid administration: Discussion of propofol and review of the literature
8. Drugs in the peri-operative period: 1. Stopping or continuing drugs around surgery
9. A guide to drug administration in palliative care
10. Administration of drugs through a jejunostomy tube
11. UK formulary of extemporaneous preparations
12. Specials manufacturing. Who makes specials and why?
13. Compatibility of medications with enteral feedings
14. Approaches and limitations of medication delivery in patients with enteral feeding tubes
15. Guide to drug therapy in patients with enteral feeding tubes: Dosage form selection and administration methods
16. How do you keep medicines from clogging feeding tubes?
17. Compatibility of enteral products with commonly employed drug additives
18. Simplifying drug therapy for patients with swallowing difficulties
19. Oral dosage forms that should not be crushed:1998 update
20. Techniques for administering oral medications to critical care patients receiving continuous enteral nutrition
21. Percutaneous endoscopic gastrostomy
22. Medication errors
23. Medication errors
24. Administering itraconazole via nasogastric tube
25. Omeprazole and lansoprazole suspensions for nasogastric administration
26. Alternative method for administering proton pump inhibitors through nasogastric tubes
27. Giving medicines through the tube
28. Stability of oral morphine sulphate solution in two enteral tube feeding products
29. Compatibility of oral morphine sulphate solution with enteral feeding products
30. In vitro stability of ranitidine hydrochloride in enteral nutrient formulas
31. Clogging of feeding tubes
32. Oesophageal bezoar resulting from enteral feedings
33. Oesophageal obstruction by solidification of the enteral feed: A complication to be prevented
34. Oesophageal obstruction secondary to concretions of tube-feeding formula
35. Causes of non-medication-induced nasogastric tube occlusion
36. Clogging of feeding tubes: A randomised trial of a newly designed tube
37. A nursing survey to determine the characteristics of medication administration through enteral feeding catheters
38. Prophylactic locking of enteral feeding tubes with pancreatic enzymes
39. Clearing obstructed feeding tubes
40. Aluminium and nasogastric feeds
41. Interaction of nutrients with antacids: A complication during enteral tube feeding
42. Phenytoin interaction with enteral feedings administered through nasogastric tubes
43. Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailability
44. Phenytoin malabsorption after jejunostomy tube delivery
45. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings
46. In vitro recovery of carbamazepine from Ensure
47. Effect of enteral feeds on anticonvulsant concentrations
48. Loss of carbamazepine suspension through nasogastric feeding tubes
49. Effects of enteral tube feeding on the absorption and pharmacokinetic profile of carbamazepine suspension
50. Rapid loading of critically ill patients with carbamazepine suspension
51. Warfarin resistance and enteral feedings
52. Pharmaco-kinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients
53. Effect of enteral feeding with Ensure on oral bioavailabilities of ofloxacin and ciprofloxacin
54. In vitro study of simultaneous infusion of incompatible drugs in multi-lumen catheters
55. Compatibility of medications with 3-in-1 parenteral nutrition admixtures
56. Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration
57. Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution
58. An analysis of potential and real cost savings by the addition of ranitidine to total parenteral nutrition solutions
59. In vitro evaluation of the stability of ranitidine hydrochloride in total parenteral nutrient mixtures
60. Warfarin resistance associated with intravenous lipid administration
61. Theophylline clearance increase from increased amino-acid in a CPN regimen
62. Theophylline disposition following parenteral feeding of malnourished patients
63. Does total parenteral nutrition lower serum phenytoin levels?
64. Effect of enteral versus parenteral feeding on hepatic blood flow and steady state propofol pharmacokinetics in ICU patients
65. Troubleshooting your tube feedings
66. Going with the flow. How to prevent feeding tubes from clogging
67. Unclogging feeding tubes with pancreatic enzyme
68. Cost-effectiveness - Is it always effective?
69. Interactions between hydralazine and oral nutrients in humans
70. Total oesophageal obstruction in association with combined oral feed and sucralfate therapy